Roost, M.S. et al. 2021. Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. Journal of Pharmacy & Pharmaceutical Sciences. 24, (Oct. 2021), 548–562. DOI:https://doi.org/10.18433/jpps32260.